Morgan Stanley Discount Zert NKE .../ DE000ME5C170 /
20/06/2024 11:57:20 | Var.+0.20 | Denaro12:47:36 | Lettera12:47:36 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
87.69EUR | +0.23% | 87.63 Quantità in denaro: 200 |
87.70 Quantità in lettera: 200 |
Nike Inc | - USD | 27/09/2024 | Call |
GlobeNewswire
13:00
Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals ...
GlobeNewswire
13:00
atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) f...
GlobeNewswire
13:00
Dragonfly Energy Unveils Next-Generation of Power Charging Solutions Under the Company’s Wakespeed® ...
GlobeNewswire
13:00
Spur Therapeutics to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Confer...
GlobeNewswire
13:00
Verano Files Court Response Seeking Full Trial and Rejecting Goodness Growth’s Damages Claim
GlobeNewswire
13:00
Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Cli...
GlobeNewswire
13:00
Village Farms International Congratulates Netherlands on Cannabis Program Milestone
GlobeNewswire
13:00
United Hydrogen Group Inc., a Comprehensive Hydrogen Solution Company in China, Announces Execution ...
GlobeNewswire
13:00
Tessera Therapeutics Presents Non-Human Primate (NHP) Data in Alpha-1 Antitrypsin Deficiency (AATD) ...
GlobeNewswire
13:00
Lantronix to Participate in ROTH 10ᵗʰ Annual London Conference Held June 26–27, 2024
GlobeNewswire
13:00
Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect...